Date |
Company |
Amount |
Funding type |
Investors |
Therapeutic area |
Type of Information |
2016-12-15 |
Valneva (France - Austria) |
€7.5 million |
private placement |
MVM Life Science Partners (UK) |
Infectious diseases - Veterinary medicine - Technology - Services |
Private placement |
2016-12-14 |
Acousia Therapeutics (Germany) |
€ 2.5 million |
financing round |
Boehringer Ingelheim Venture Fund (BIVF) (Germany) KfW (Germany) Axxam (Italy) |
Otorhinolaryngology |
Financing round |
2016-12-13 |
CytRx Corporation (USA - CA) |
$7.4 million |
private placement |
existing institutional investors |
Cancer - Oncology |
Private placement |
2016-12-12 |
BlueRock Therapeutics (USA - Canada) |
$ 225 million |
series A financing round |
Bayer Healthcare (Germany) Versant Ventures (USA - CA) |
Cardiovascular diseases - Neurodegenerative diseases |
Series A financing round |
2016-12-12 |
Herantis Pharma (Finland) TreatER project |
€ 6 million |
grant |
European Commission’s Horizon 2020 programme |
CNS diseases - Neurological diseases |
Grant |
2016-12-12 |
EURE-CART (EURopean Endeavour for Chimeric Antigen Receptor Therapies) project coordinated by Molmed (Italy) |
€ 5.9 million |
grant |
European Commission’s Horizon 2020 programme |
Cancer - Oncology |
Grant |
2016-12-05 |
Ixchelsis (UK) |
$ 12 million |
financing round |
TVM Life Science VII (Canada) Pfizer Venture Investments (USA - NY) |
Urological diseases |
Financing round |
2016-12-02 |
Cerevance (USA - MA) |
$36 million |
series A financing round |
Takeda Pharmaceutical (Japan) Lightstone Ventures (USA - CA) |
CNS diseases - Mental diseases - Neurological diseases |
Series A financing round |
2016-12-02 |
Amryt Pharma (Ireland) |
€ 20 million |
loan |
European Investment Bank (EIB) |
Rare diseases |
Loan |
2016-12-01 |
Inovio Pharmaceuticals (USA - PA) |
$6.1 million |
grant |
|
Infectious diseases |
Grant |
2016-11-29 |
Cytune Pharma (France) |
€ 6 million |
financing round |
PPF Group (Czech Republic) founding shareholders |
Cancer - Oncology - Infectious diseases |
Financing round |
2016-11-24 |
Kymab (UK) |
$100 million (£81 million) |
series C financing round |
ORI Fund (China) Hepalink Pharmaceutical (China) Wellcome Trust (UK) Bill & Melinda Gates Foundation (USA) Malin Corporation (UK) CF Woodford Equity Income Fund (UK) Woodford Patient Capital (UK) |
|
Series C financing round |
2016-11-23 |
Orchard Therapeutics (UK) University of California, Los Angeles (USA - CA) |
$20 million |
grant |
California’s stem cell agency (USA - CA) |
Rare diseases - Genetic diseases |
Grant |
2016-11-22 |
Fate Therapeutics (USA - CA) |
$57 million |
private placement |
|
Cancer - Oncology - Immunological diseases |
Private placement |
2016-11-16 |
Glycomine (USA - CA) |
$12 million |
series A financing round |
Chiesi Ventures (USA - MA) Sanderling Ventures (USA - CA) existing high net worth individuals and patients |
Rare diseases - Genetic diseases |
Series A financing round |
2016-11-15 |
Morphosys (Germany) |
€ 115 million |
private placement |
|
Cancer - Oncology - Inflammatory diseases |
Private placement |
2016-11-10 |
Transgene (France) |
€46.4 million |
capital increase |
Institut Mérieux (France) |
Cancer - Oncology - Infectious diseases |
Capital increase |
2016-11-09 |
Merus (The Netherlands) Aquila BioMedical (UK) |
€1.5 million |
grant |
European Eurostars Programme (EU) |
Cancer - Oncology |
Grant |
2016-11-08 |
Curevac (Germany) |
$29.5 million |
financing round |
Baden-Württembergische Versorgungsanstalt für Ärzt (Germany) Zahnärzte und Tierärzte (via the LBBW Asset Management Investmentgesellschaft (Germany) Landeskreditbank Baden-Württemberg (Germany) |
|
Financing round |
2016-11-04 |
Plasticell (UK) |
£1.32 million (€1.48 million) |
financing round |
|
Cancer - Oncology |
Fundraising |